Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

by Cristina Regueiro, Laura Nuño, Ana M. Ortiz, Diana Peiteado, Alejandro Villalba, Dora Pascual-Salcedo, Ana Martínez-Feito, Isidoro González-Alvaro, Alejandro Balsa, Antonio González
Published 2017

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies

by Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, Ana M. Ortiz, Alejandro Villalba, María Dolores Bóveda, Ana Martínez-Feito, Carmen Conde, Alejandro Balsa, Isidoro González-Alvaro, Antonio Gonzalez
Published 2021

The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis

by Sara Fuentelsaz-Romero, Celia Barrio-Alonso, Raquel García Campos, Mónica Torres Torresano, Ittai B. Muller, Ana Triguero-Martínez, Laura Nuño, Alejandro Villalba, Rosario García-Vicuña, Gerrit Jansen, María-Eugenia Miranda-Carús, Isidoro González-Álvaro, Amaya Puig-Kröger
Published 2021

Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.

by Mercedes García-Bermúdez, Carlos González-Juanatey, Raquel López-Mejías, María Teruel, Alfonso Corrales, José A Miranda-Filloy, Santos Castañeda, Alejandro Balsa, Benjamín Fernández-Gutierrez, Isidoro González-Álvaro, Carmen Gómez-Vaquero, Ricardo Blanco, Javier Llorca, Javier Martín, Miguel A González-Gay
Published 2012

Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

by Rosario López-Rodríguez, Aida Ferreiro-Iglesias, Aurea Lima, Miguel Bernardes, Andrzej Pawlik, Agnieszka Paradowska-Gorycka, Jerzy Świerkot, Ryszard Slezak, Vita Dolžan, Isidoro González-Álvaro, Javier Narváez, Rafael Cáliz, Eva Pérez-Pampín, Antonio Mera-Varela, Laura Vidal-Bralo, José Gorgonio Acuña Ochoa, Carmen Conde, Juan J. Gómez-Reino, Antonio González
Published 2018

Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

by Diego A. Rodríguez-Serrano, Emilia Roy-Vallejo, Nelly D. Zurita Cruz, Alexandra Martín Ramírez, Sebastián C. Rodríguez-García, Nuria Arevalillo-Fernández, José María Galván-Román, Leticia Fontán García-Rodrigo, Lorena Vega-Piris, Marta Chicot Llano, David Arribas Méndez, Begoña González de Marcos, Julia Hernando Santos, Ana Sánchez Azofra, Elena Ávalos Pérez-Urria, Pablo Rodriguez-Cortes, Laura Esparcia, Ana Marcos-Jimenez, Santiago Sánchez-Alonso, Irene Llorente, Joan Soriano, Carmen Suárez Fernández, Rosario García-Vicuña, Julio Ancochea, Jesús Sanz, Cecilia Muñoz-Calleja, Rafael de la Cámara, Alfonso Canabal Berlanga, Isidoro González-Álvaro, Laura Cardeñoso, the REINMUN-COVID Group
Published 2021